The launch of generic semaglutide in India after patent expiry has reshaped the domestic GLP-1 market, with expectations of ...

Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

Cipla will not enter the market with its generic sodium thiosulfate product until Sept.1, 2033, or earlier under certain ...

Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

Cipla Health Limited introduces a new Masala Guava flavor for ProlyteORS, enhancing hydration with Indian-inspired taste. The launch strengthens Cipla's commitment to effective oral rehydration ...

Analysts have adjusted targets for several companies, with UBS neutral on Cipla citing supply headwinds despite a healthy ...

Cipla, which was recently hit with a 23-page Form 483 filing from the FDA, is adding to the albuterol supply strain with a U.S. recall of six batches of the asthma med. The company's voluntary recall ...

(Reuters) -Cipla's global chief executive and managing director, Umang Vohra, will step down at the end of March after almost a decade in the top role, the Indian drugmaker said on Thursday. Achin ...

Cipla consolidated net profit for the quarter ending June 2025 at ₹1291.61 crore increased 10% compared to ₹1,175.46 crore in the year-ago quarter. The company's revenue from operations stood at ...

Cipla, through its wholly-owned subsidiary Meditab Holdings Ltd (MHL), has acquired an additional 14.5 per cent stake in Quality Chemical Industries Ltd (QCIL), Uganda, for $15 million, as per a stock ...